Quick Answer
NEOGEN CORP reported Total Revenue of $894.66 million for fiscal year 2025.
NEOGEN CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $894.66M -3.2% |
$924.22M +12.4% |
$822.45M +56.0% |
$527.16M +12.5% |
$468.46M +12.0% |
$418.17M +1.0% |
| Revenue (ASC 606) | $894.66M -3.2% |
$924.22M +12.4% |
$822.45M +56.0% |
$527.16M +12.5% |
$468.46M +12.0% |
$418.17M +1.0% |
| Net Income | — | — | — | — | — | $59.48M -1.2% |
| Diluted EPS | -$5.03 -12475.0% |
-$0.04 +66.7% |
-$0.12 -126.7% |
$0.45 -21.1% |
$0.57 +1.8% |
$0.56 -1.8% |
| Total Assets | $3.44B -24.3% |
$4.55B -0.1% |
$4.55B +358.7% |
$992.93M +7.9% |
$920.19M +15.4% |
$797.18M +14.6% |
| Cash and Equivalents | $129.00M -24.4% |
$170.61M +4.5% |
$163.24M +267.1% |
$44.47M -41.2% |
$75.60M +14.1% |
$66.27M +59.0% |
| Long-Term Debt | $874.81M -1.5% |
$888.39M +0.3% |
$885.44M | — | — | — |
| Stockholders Equity | $2.07B -34.1% |
$3.14B +0.3% |
$3.13B +253.2% |
$887.37M +5.6% |
$840.38M +15.9% |
$725.18M +13.7% |
| R&D Expense | $21.09M -6.2% |
$22.48M -13.7% |
$26.04M +52.7% |
$17.05M +4.9% |
$16.25M +10.1% |
$14.75M +15.2% |
| Operating Income | -$1.06B -1908.6% |
$58.66M +56.4% |
$37.52M -36.0% |
$58.62M -21.0% |
$74.17M +9.8% |
$67.52M -0.8% |
| Gross Profit | $421.38M -9.2% |
$463.90M +14.3% |
$405.95M +67.1% |
$243.01M +13.0% |
$215.06M +9.6% |
$196.28M +2.3% |
| Shares Outstanding | 216.61M -0.2% |
217.04M +0.4% |
216.25M +100.6% |
107.80M +0.3% |
107.47M +1.5% |
105.89M +102.8% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | November 30, 2025 | $224.69M | -2.8% | +7.4% |
| Revenue (ASC 606) | November 30, 2025 | $224.69M | -2.8% | +7.4% |
| Net Income | February 29, 2020 | $12.20M | -6.7% | -25.0% |
| Diluted EPS | November 30, 2025 | -$0.07 | +96.7% | -141.2% |
| Total Assets | November 30, 2025 | $3.36B | -17.1% | -0.5% |
| Cash and Equivalents | November 30, 2025 | $145.34M | +3.6% | +4.6% |
| Long-Term Debt | November 30, 2025 | $792.93M | -10.9% | +0.0% |
| Stockholders Equity | November 30, 2025 | $2.10B | -21.2% | -0.7% |
| R&D Expense | November 30, 2025 | $4.56M | -10.7% | -11.0% |
| Operating Income | November 30, 2025 | -$5.38M | +98.8% | +66.6% |
| Gross Profit | November 30, 2025 | $106.68M | -5.9% | +12.3% |
| Shares Outstanding | November 30, 2025 | 217.53M | +0.3% | +0.1% |
- NEOGEN CORP reported Total Revenue of $894.66 million for fiscal year 2025.
- NEOGEN CORP showed a decrease of -3.2% in Total Revenue compared to the prior fiscal year.
- NEOGEN CORP reported Revenue (ASC 606) of $894.66 million for fiscal year 2025.
- NEOGEN CORP showed a decrease of -3.2% in Revenue (ASC 606) compared to the prior fiscal year.
- NEOGEN CORP reported Net Income of $59.48 million for fiscal year 2020.
- NEOGEN CORP showed a decrease of -1.2% in Net Income compared to the prior fiscal year.
- NEOGEN CORP reported Diluted EPS of $5.03 per share (loss) for fiscal year 2025.
- NEOGEN CORP showed a decrease of -12475.0% in Diluted EPS compared to the prior fiscal year.
- NEOGEN CORP reported Total Assets of $3.44 billion for fiscal year 2025.
- NEOGEN CORP showed a decrease of -24.3% in Total Assets compared to the prior fiscal year.
- NEOGEN CORP reported Cash and Equivalents of $129.00 million for fiscal year 2025.
- NEOGEN CORP showed a decrease of -24.4% in Cash and Equivalents compared to the prior fiscal year.
- NEOGEN CORP reported Long-Term Debt of $874.81 million for fiscal year 2025.
- NEOGEN CORP showed a decrease of -1.5% in Long-Term Debt compared to the prior fiscal year.
- NEOGEN CORP reported Stockholders Equity of $2.07 billion for fiscal year 2025.
- NEOGEN CORP showed a decrease of -34.1% in Stockholders Equity compared to the prior fiscal year.
- NEOGEN CORP reported R&D Expense of $21.09 million for fiscal year 2025.
- NEOGEN CORP showed a decrease of -6.2% in R&D Expense compared to the prior fiscal year.
- NEOGEN CORP reported Operating Income of -$1.06 billion for fiscal year 2025.
- NEOGEN CORP showed a decrease of -1908.6% in Operating Income compared to the prior fiscal year.
- NEOGEN CORP reported Gross Profit of $421.38 million for fiscal year 2025.
- NEOGEN CORP showed a decrease of -9.2% in Gross Profit compared to the prior fiscal year.
- NEOGEN CORP reported Shares Outstanding of 216.61 million shares for fiscal year 2025.
- NEOGEN CORP showed a decrease of -0.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: